GEM OS^®1:
Technology with a history of safe and effective use

A fully synthetic, biocompatible material
Composed of beta tricalcium phosphate (ß-TCP) and recombinant platelet-derived growth factor (rhPDGF-BB), a recombinant human platelet-derived growth factor,
GEM OS1 is designed to fill bone defects and provide a “scaffold” for new bone formation and the promotion of cellular growth. Both components have been approved by the FDA and are chemically identical to those found in the GEM 21S^® device approved in the U.S. and Canada for bone regeneration in the jaw.

Easy to use
The GEM OS1 kit contains a package of ß-TCP and a syringe containing a solution of 0.3 mg/ml rhPDGF-BB. After mixing, the graft material is packed into and around the fusion site using standard surgical techniques to complete the procedure.

A less invasive procedure
Because there is no need to harvest autologous bone, fusion procedures using GEM OS1 have potential benefits, such as decreased pain and anesthesia time.

If you have any questions or feel you have patients who may benefit from this study, call 1-615-844-1280 or please contact us.